CROs Doing More Research, Discovery

August 3, 2011

August 2, 2011 | CRO's portion of the drug discovery market is expanding rapidly. In 2010 about 21 percent of R&D spending worldwide went to CROs--up from 16.7 percent in 2007. In the US, CRO revenue grew at an average annual rate of almost 10% over the last five years and is set to double by 2017. San Diego Union Tribune